The traffic tells the real story: 650 monthly visits to chronometriq.com itself, yet $30M in revenue. This isn't a consumer-facing failure—it's a strategic masterstroke. The company powers Telus Santé's appointment system (evidenced by their top keywords like 'telus santé' and 'acces rendez vous telus santé'), operating as the invisible infrastructure layer. Users never visit chronometriq.com; they interact with branded interfaces that Chronometriq quietly powers. It's B2B2C at its finest: capture enterprise contracts, let partners own the customer relationship, and scale through integration rather than marketing.

Healthcare scheduling isn't sexy, but it's brutally defensible. Once a system like Telus Santé integrates Chronometriq's APIs into their patient portal, switching costs become astronomical. The 42% direct traffic suggests internal teams and partners accessing the backend directly—this is stickiness born from mission-critical dependency. The $6.4M funding round likely went into compliance, security audits, and enterprise sales cycles that startups can't replicate. This isn't a growth hack business; it's a regulatory moat business.